(S (NP-SBJ (NN Interleukin-6)) (VP (VBZ promotes) (NP (JJ multiple) (NN myeloma) (NN cell) (NN growth)) (PP (IN via) (NP (NP (NN phosphorylation)) (PP (IN of) (NP (NN retinoblastoma) (NN protein)))))) (. .))
(S (NP-SBJ (NP (NN Interleukin-6)) (PRN (-LRB- -LRB-) (NP (NN IL-6)) (-RRB- -RRB-))) (VP-COOD (VP (VBZ mediates) (NP (NP (ADJP-COOD (ADJP (NN autocrine)) (CC and) (ADJP (NN paracrine))) (NN growth)) (PP (IN of) (NP (NP (NP (JJ multiple) (NN myeloma)) (PRN (-LRB- -LRB-) (NP (NN MM)) (-RRB- -RRB-))) (NNS cells))))) (CC and) (VP (VBZ inhibits) (NP (NN tumor) (NN cell) (NN apoptosis)))) (. .))
(S (NP-SBJ-COOD-18 (NP (NP (NNS Abnormalities)) (PP (IN of) (NP (NP (NN retinoblastoma) (NN protein)) (PRN (-LRB- -LRB-) (NP (NN pRB)) (-RRB- -RRB-))))) (CC and) (NP (NP (NNS mutations)) (PP (IN of) (NP (NN RB) (NN gene))))) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (NP (-NONE- *-18)) (PP (IN in) (NP-COOD (NP (NP (QP (IN up) (TO to) (CD 70)) (NN %)) (PP (IN of) (NP (NN MM) (NNS patients)))) (CC and) (NP (NP (CD 80) (NN %)) (PP (IN of) (NP (JJ MM-derived) (NN cell) (NNS lines))))))))) (. .))
(S (SBAR (IN Because) (S-COOD (S (NP-SBJ (ADJP (ADJP (VBN dephosphorylated)) (PRN (-LRB- -LRB-) (ADJP (VBN activated)) (-RRB- -RRB-))) (NN pRB)) (VP (VBZ blocks) (NP (NP (NN transition)) (PP (IN from) (NP (NP (NN G1) (NP (-NONE- *RNR*-19))) (PP (-NONE- *RNR*-20)))) (PP (TO to) (NP (NP (NN S) (NP (-NONE- *RNR*-19))) (PP (-NONE- *RNR*-20)))) (NP-19 (NN phase)) (PP-20 (IN of) (NP (DT the) (NN cell) (NN cycle)))))) (IN whereas) (S (NP-SBJ (ADJP (ADJP (VBN phosphorylated)) (PRN (-LRB- -LRB-) (ADJP (VBN inactivated)) (-RRB- -RRB-))) (NN pRB)) (VP (VBZ releases) (NP (DT this) (NN growth) (NN arrest)))))) (, ,) (NP-SBJ (PRP we)) (VP (VBD characterized) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (NN pRB))) (PP (IN in) (NP (JJ IL-6-mediated) (NN MM) (NN cell) (NN growth))))) (. .))
(S-COOD (S (NP-SBJ-22 (ADJP-COOD (CC Both) (ADJP (VBN phosphorylated)) (CC and) (ADJP (VBN dephosphorylated))) (NN pRB)) (VP (VBD were) (VP (VBN expressed) (NP (-NONE- *-22)) (PP (IN in) (NP (DT all) (NP-COOD (NP (JJ serum-starved) (NN MM) (NN patient) (NNS cells)) (CC and) (NP (JJ MM-derived) (NN cell) (NNS lines)))))))) (, ,) (CC but) (S (NP-SBJ (NN pRB)) (VP (VBD was) (ADVP (RB predominantly)) (PP-PRD (IN in) (NP (PRP$ its) (JJ phosphorylated) (NN form))))) (. .))
(S (PP (IN In) (NP (NP (NN MM) (NNS cells)) (SBAR (WHNP-23 (WDT that)) (S (NP-SBJ (-NONE- *T*-23)) (VP (VBD proliferated) (PP (IN in) (NN response) (TO to) (NP (NN IL-6)))))))) (, ,) (NP-SBJ (JJ exogenous) (NN IL-6)) (VP-COOD (VP (VBD downregulated) (NP (VBN dephosphorylated) (NN pRB))) (CC and) (VP (VBD decreased) (NP (VBN dephosphorylated) (NN pRB-E2F) (NNS complexes)))) (. .))
(S (S (ADVP (RB Importantly)) (, ,) (NP-SBJ (NP (NN culture)) (PP (IN of) (NP (NP (NN MM) (NNS cells)) (PP (IN with) (NP (ADJP-COOD (ADJP (NN RB) (JJ antisense)) (, ,) (CC but) (ADJP (RB not) (NN RB) (NN sense)) (, ,)) (NP (NP (NN oligonucleotide)) (PRN (-LRB- -LRB-) (NP (NN ODN)) (-RRB- -RRB-)))))))) (VP (VBD triggered) (NP (NP (NN IL-6) (NP-COOD (NP (NN secretion)) (CC and) (NP (NN proliferation)))) (PP (IN in) (NP (NN MM) (NNS cells))))) (: ;)) (S (ADVP (RB however)) (, ,) (NP-SBJ-24 (NN proliferation)) (VP (VBD was) (ADVP (RB only) (RB partially)) (VP (VBN inhibited) (NP (-NONE- *-24)) (PP (IN by) (S-LGS (NP-SBJ (-NONE- *)) (VP (VBG neutralizing) (NP (JJ anti-IL-6) (NP (NP (JJ monoclonal) (NN antibody)) (PRN (-LRB- -LRB-) (NP (NN MoAb)) (-RRB- -RRB-))))))))) (. .)))
(S (PP (IN In) (NN contrast) (TO to) (NP (NN MM) (NNS cells))) (, ,) (NP-SBJ (JJ normal) (JJ splenic) (NN B) (NNS cells)) (VP (VBP express) (NP (VBN dephosphorylated) (NN pRB))) (. .))
(S (SBAR (IN Although) (S (NP-SBJ (NP (NN CD40) (NN ligand)) (PRN (-LRB- -LRB-) (NP (NN CD40L)) (-RRB- -RRB-))) (VP (VBZ triggers) (NP-COOD (NP (NP (DT a) (NN shift)) (PP (IN from) (NP (VBN dephosphorylated) (NP (-NONE- *RNR*-25)))) (PP (TO to) (NP (VBN phosphorylated) (NP (-NONE- *RNR*-25)))) (NP-25 (NN pRB))) (CC and) (NP (NP (NN proliferation)) (PP (IN of) (NP (NN B) (NNS cells)))))))) (, ,) (NP-SBJ (NP (DT the) (NN addition)) (PP (IN of) (NP (JJ exogenous) (NN IL-6))) (PP (TO to) (NP (JJ CD40L-treated) (NN B) (NNS cells)))) (VP (VBZ does) (RB not) (VP (VB alter) (NP-COOD (CC either) (NP (NN pRB)) (CC or) (NP (NN proliferation))) (, ,) (SBAR (IN as) (S (NP-SBJ-26 (-NONE- *)) (VP (VBN observed) (NP (-NONE- *-26)) (PP (IN in) (NP (NN MM) (NNS cells)))))))) (. .))
(S (NP-SBJ (DT These) (NNS results)) (VP (VBP suggest) (SBAR-COOD (SBAR (IN that) (S (NP-SBJ-27 (VBN phosphorylated) (NN pRB)) (VP (VBZ is) (ADVP (RB constitutively)) (VP (VBN expressed) (NP (-NONE- *-27)) (PP (IN in) (NP (JJ MM) (NNS cells))))))) (CC and) (SBAR (IN that) (S (NP-SBJ-29 (NN IL-6)) (ADVP (RB further)) (VP (VBZ shifts) (NP (NN pRB)) (PP (IN from) (NP (PRP$ its) (JJ dephosphorylated) (NP (-NONE- *RNR*-28)))) (PP (TO to) (NP (PRP$ its) (JJ phosphorylated) (NP (-NONE- *RNR*-28)))) (NP-28 (NN form)) (, ,) (S (NP-SBJ (-NONE- *-29)) (ADVP (RB thereby)) (VP (VBG promoting) (NP (NN MM) (NN cell) (NN growth)) (PP (IN via) (NP (NP (CD two) (NNS mechanisms)) (: ;) (PP-COOD (PP (IN by) (S (NP-SBJ-30 (-NONE- *)) (VP (VBG decreasing) (NP (NP (DT the) (NN amount)) (PP (IN of) (NP (NP (NN E2F)) (VP (VBN bound) (NP (-NONE- *)) (PP (IN by) (NP-LGS (VBN dephosphorylated) (NN pRB))))))) (PP (IN due) (TO to) (NP (VBN reduced) (VBN dephosphorylated) (NN pRB))) (, ,) (S (NP-SBJ (-NONE- *-30)) (ADVP (RB thereby)) (VP (VBG releasing) (NP (NN growth) (NN arrest))))))) (: ;) (CC and) (PP (IN by) (S (NP-SBJ (-NONE- *)) (VP (VBG upregulating) (NP-COOD (NP (NP (NN IL-6) (NN secretion)) (PP (IN by) (NP (NN MM) (NNS cells)))) (CC and) (NP (JJ related) (JJ IL-6-mediated) (JJ autocrine) (NN tumor) (NN cell) (NN growth)))))))))))))))) (. .))
